Hosted on MSN
Quest launches flow cytometry MRD test for myeloma
Quest Diagnostics has introduced a new flow cytometry measurable residual disease (MRD) blood test for myeloma, a cancer arising from abnormal plasma cells. The test aims to enhance ultra-sensitive ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
While thrombocytopenia and bleeding are events that often occur together in neonates, this may not signify cause and effect. In fact, one study reported that 91% of neonates with low platelet counts ...
Researchers at Heidelberg University Hospital have developed a PBMC-based proof-of-principle framework for fit-for-purpose ...
SALT LAKE CITY, July 20, 2026 /PRNewswire/ -- ARUP Laboratories today announced the launch of ARUP CLARISPECT™ Multiple Myeloma MRD by Spectral Flow Cytometry. The new assay will characterize small ...
Sysmex America, Inc., a leading diagnostic solutions company offering hematology, urinalysis, information systems and flow cytometry testing technology for optimal clinical laboratory performance, ...
Back in December 2019, a cluster of patients in Wuhan, China, developed pneumonia of an unknown etiology. Since then, the full genome of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 ...
SAN ANTONIO--(BUSINESS WIRE)-- bioAffinity Technologies’ (Nasdaq: BIAF; BIAFW) Vice President of Diagnostics, Jennifer Rebeles, Ph.D., was part of a panel of worldwide experts that published the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results